This IDC FutureScape provides retail IT executives across the globe with actionable insights and analysis for likely future technology and business scenarios. The intended readers of this IDC FutureScape include but are not limited to members of the executive, business, and IT leadership of retail organizations worldwide.
Life sciences supply chains need to adjust to increasingly complex environments globally. Pharma manufacturers and wholesalers in Europe must undergo a fundamental transformation to remain competitive in this market. The rapidly approaching deadline of the European Union’s Falsified Medicines Directive (FMD) for drug serialization and traceability is currently the top concern of life science companies supplying pharmaceutical products to the European markets. However, companies can take this opportunity to upgrade their digital systems and operations and realize the broader potential of the 3rd platform and innovation accelerator technologies to achieve “smart compliance,” deriving a longer-term business value for their supply chains.
Providing a differentiated customer experience is becoming more difficult for brands. Yes, customers are integrating more technology into their lives that results in more channels engage with and more data for the brand, it also makes it more difficult to provide a consistent experience across those channels to effectively and contextually target those customers with the right experience without more technology. It is becoming a never-ending cycle.
IT leaders have never had so much choice in their infrastructure strategies, on-premises, off-premises, and the increasingly common hybrid model. With this expanding range of choices comes the potential to positively impact budgets, staffing, operational effectiveness, and business outcomes by reaching the right balance.